- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Filed S-1/A: Generation Bio Launches 7.4mm Share IPO with $16-$18 Marketing Range
Generation Bio
Nasdaq: GBIO
Filing Date: 05/22/20
Launch Date: 06/08/20
Price Range: $16.00 - $18.00
Shares Offered (Pre-Shoe, mm): 7.4
Primary Shares (mm): 7.4
Secondary Shares (mm): 0.0
Amount Offered (@ Midpoint)(mm): $125.8
% Secondary: 0.0%
Shares Outstanding (mm): 41.5
Market Value at IPO Midpoint (mm): $705.6
Offering as % of Market Value: 17.8%
Bookrunners: J.P. Morgan | Jefferies | Cowen
Co-Manager: Wedbush
Major Holders: Atlas Venture Fund | Fidelity | T. Rowe Price | Invus Public Equities
Description: Generation Bio is an innovative genetic medicines company creating a new class of gene therapy utilizing their proprietary non-viral gene therapy platform to provide durable, redosable treatments for millions of patients living with rare and prevalent diseases.
Note: Emerging Growth Company
Reference Link: S-1/A